ARTIMEG-ARTESUNATE 60 INJ contains Artesunate 60 mg, an antimalarial medicine used for the treatment of severe malaria. Artesunate acts rapidly against malaria parasites and is particularly important in the initial management of severe Plasmodium falciparum malaria.
Artesunate injection is generally administered in hospital or clinical settings. For uncomplicated malaria, artesunate is used as part of an appropriate artemisinin-based combination therapy (ACT) rather than as monotherapy, according to the prescribed treatment regimen.
Composition:
- Artesunate – 60 mg
- Dosage form: Injection
Indications / Uses
- Severe malaria
- Severe Plasmodium falciparum malaria
- Uncomplicated P. falciparum malaria as part of an appropriate ACT regimen
- Malaria infections requiring parenteral artesunate therapy, as clinically indicated
Key Benefits
- Rapid antimalarial activity
- Important first-line therapy for severe malaria
- Helps rapidly reduce malaria parasite levels
- Effective against susceptible Plasmodium falciparum
- Suitable for hospital and clinical management of severe malaria
Important: ARTIMEG-ARTESUNATE 60 INJ should be administered by a qualified healthcare professional. Severe malaria requires urgent medical treatment and monitoring. Artesunate injection should be followed by a complete appropriate antimalarial regimen as recommended by the treating healthcare professional. It should not be used for self-medication.
